Multidrug-resistant Pseudomonas aeruginosa bloodstream infections:: Analysis of trends in prevalence and epidemiology

被引：66
|
作者：
Tacconelli, E [1 ]
Tumbarello, M [1 ]
Bertagnolio, S [1 ]
Citton, R [1 ]
Spanu, T [1 ]
Fadda, G [1 ]
Cauda, R [1 ]
机构：
[1] Catholic Univ Rome, Rome, Italy
来源：
EMERGING INFECTIOUS DISEASES | 2002年 / 8卷 / 02期
关键词：
D O I：
10.3201/eid0802.010121
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：220 / 221
页数：2
相关论文
共 50 条
  • [31] Prevalence of Multidrug-Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacteriaceae Among Specimens From Hospitalized Patients With Pneumonia and Bloodstream Infections in the United States From 2000 to 2009
    Zilberberg, Marya D.
    Shorr, Andrew F.
    JOURNAL OF HOSPITAL MEDICINE, 2013, 8 (10) : 559 - 563
  • [32] Gene regulatory network inference and analysis of multidrug-resistant Pseudomonas aeruginosa
    Medeiros Filho, Fernando
    Barbosa do Nascimento, Ana Paula
    dos Santos, Marcelo Trindade
    D'Alincourt Carvalho-Assef, Ana Paula
    Barbosa da Silva, Fabricio Alves
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2019, 114
  • [33] Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa
    Sabuda, Deana M.
    Laupland, Kevin
    Pitout, Johann
    Dalton, Bruce
    Rabin, Harvey
    Louie, Thomas
    Conly, John
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2008, 19 (06): : 413 - 418
  • [34] Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
    Coyne, Ashlan J. Kunz
    El Ghali, Amer
    Holger, Dana
    Rebold, Nicholas
    Rybak, Michael J.
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (02) : 661 - 682
  • [35] Phage therapy in lung infections caused by multidrug-resistant Pseudomonas aeruginosa - A literature review
    Eiselt, Vincent A.
    Bereswill, Stefan
    Heimesaat, Markus M.
    EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY, 2024, 14 (01): : 1 - 12
  • [36] Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study
    Gallagher, Jason C.
    Satlin, Michael J.
    Elabor, Abdulrahman
    Saraiya, Nidhi
    McCreary, Erin K.
    Molnar, Esther
    El-Beyrouty, Claudine
    Jones, Bruce M.
    Dixit, Deepali
    Heil, Emily L.
    Claeys, Kimberly C.
    Hiles, Jon
    Vyas, Nikunj M.
    Bland, Christopher M.
    Suh, Jin
    Biason, Kenneth
    McCoy, Dorothy
    King, Madeline A.
    Richards, Lynette
    Harrington, Nicole
    Guo, Yi
    Chaudhry, Saira
    Lu, Xiaoning
    Yu, Daohai
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (11):
  • [37] Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
    Raman, Gowri
    Avendano, Esther E.
    Chan, Jeffrey
    Merchant, Sanjay
    Puzniak, Laura
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2018, 7
  • [38] Novel therapies of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter spp . infections: the state of the art
    Marta Wróblewska
    Archivum Immunologiae et Therapiae Experimentalis, 2006, 54 : 113 - 120
  • [39] Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
    Gowri Raman
    Esther E. Avendano
    Jeffrey Chan
    Sanjay Merchant
    Laura Puzniak
    Antimicrobial Resistance & Infection Control, 7
  • [40] Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients
    Hachem, Ray Y.
    Chemaly, Roy F.
    Ahmar, Corine A.
    Jiang, Ying
    Boktour, Maha R.
    Abou Rjaili, Georges
    Bodey, Gerald P.
    Raad, Issam I.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) : 1905 - 1911
12345